Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 4 (2007), Issue 10 (October)

1. Global histone modifications predict prognosis of resected non small-cell lung cancer.
   J Clin Oncol, 25(28): 4358-64. [Abstract] [Full-text]
2. Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer.
   J Clin Oncol, 25(28): 4350-7. [Abstract] [Full-text]
3. Radiation-induced lung adenocarcinoma is associated with increased frequency of genes inactivated by promoter hypermethylation.
   Radiat Res, 168(4): 409-14. [Abstract] [Full-text]
4. Recombined CC chemokine ligand 2 into B16 cells induces production of Th2-dominant [correction of dominanted] cytokines and inhibits melanoma metastasis.
   Immunol Lett, 113(1): 19-28. [Abstract] [Full-text]
5. ATM sequence variants associate with susceptibility to non-small cell lung cancer.
   Int J Cancer, 121(10): 2254-9. [Abstract] [Full-text]
6. Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer.
   J Natl Cancer Inst, 99(19): 1455-61. [Abstract] [Full-text]
7. Endobronchial ultrasonography: current status and future directions.
   J Thorac Oncol, 2(10): 970-9. [Abstract] [Full-text]
8. Irinotecan-cisplatin therapy for patients with extensive-stage small cell lung cancer: use patterns among American medical oncologists 2000-2006.
   J Thorac Oncol, 2(10): 953-6. [Abstract] [Full-text]
9. Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levels.
   J Thorac Oncol, 2(10): 947-52. [Abstract] [Full-text]
10. Comparison of docetaxel- and vinca alkaloid-based chemotherapy in the first-line treatment of advanced non-small cell lung cancer: a meta-analysis of seven randomized clinical trials.
    J Thorac Oncol, 2(10): 939-46. [Abstract] [Full-text]
11. Docetaxel and exisulind in previously treated non-small cell lung cancer (NSCLC) patients: a multicenter, phase II clinical trial.
    J Thorac Oncol, 2(10): 933-8. [Abstract] [Full-text]
12. Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.
    J Thorac Oncol, 2(10): 927-32. [Abstract] [Full-text]
13. Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week.
    J Thorac Oncol, 2(10): 916-26. [Abstract] [Full-text]
14. Restaging of mediastinal nodes with transbronchial needle aspiration after induction chemoradiation for locally advanced non-small cell lung cancer.
    J Thorac Oncol, 2(10): 912-5. [Abstract] [Full-text]
15. Postoperative prognosis in patients with non-small cell lung cancer according to the method of initial detection.
    J Thorac Oncol, 2(10): 907-11. [Abstract] [Full-text]
16. ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer.
    J Thorac Oncol, 2(10): 902-6. [Abstract] [Full-text]
17. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.
    J Thorac Oncol, 2(10): 893-901. [Abstract] [Full-text]
18. Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer.
    Cancer Res, 67(19): 9356-63. [Abstract] [Full-text]
19. The alternative reading frame tumor suppressor antagonizes hypoxia-induced cancer cell migration via interaction with the COOH-terminal binding protein corepressor.
    Cancer Res, 67(19): 9322-9. [Abstract] [Full-text]
20. Glutathione transferase pi plays a critical role in the development of lung carcinogenesis following exposure to tobacco-related carcinogens and urethane.
    Cancer Res, 67(19): 9248-57. [Abstract] [Full-text]
21. Loss of the mitochondrial bioenergetic capacity underlies the glucose avidity of carcinomas.
    Cancer Res, 67(19): 9013-7. [Abstract] [Full-text]
22. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
    Intern Med J, 37(11): 753-9. [Abstract] [Full-text]
23. Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer.
    Int J Cancer, 121(11): 2387-94. [Abstract] [Full-text]
24. Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancer.
    Int J Cancer, 121(11): 2575-7. [Abstract] [Full-text]
25. The gemcitabine, docetaxel, and capecitabine (GTX) regimen for metastatic pancreatic cancer: a retrospective analysis.
    Cancer Chemother Pharmacol, 61(1): 167-75. [Abstract] [Full-text]
26. Syndromic presentation of a pleuropulmonary blastoma associated with congenital cystic adenomatoid malformation. A case report.
    J Pediatr Surg, 42(10): 1772-5. [Abstract] [Full-text]
27. Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review.
    Cancer, 110(8): 1654-64. [Abstract] [Full-text]
28. Hormone replacement therapy and lung cancer risk in Chinese.
    Cancer, 110(8): 1768-75. [Abstract] [Full-text]
29. Treatment outcomes of small cell carcinoma of the prostate: a single-center study.
    Cancer, 110(8): 1729-37. [Abstract] [Full-text]
30. Prognostic significance of synaptophysin in stage I of squamous carcinoma and adenocarcinoma of the lung.
    Cancer, 110(8): 1776-81. [Abstract] [Full-text]
31. Quality of integrated care for patients with nonsmall cell lung cancer: variations and determinants of care.
    Cancer, 110(8): 1782-90. [Abstract] [Full-text]
32. Cisplatin plus gemcitabine or vinorelbine for elderly patients with advanced non small-cell lung cancer: the MILES-2P studies.
    J Clin Oncol, 25(29): 4663-9. [Abstract] [Full-text]
33. Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells.
    Cancer Gene Ther, 14(11): 894-903. [Abstract] [Full-text]
34. Bid is not required for Bax translocation during UV-induced apoptosis.
    Cell Signal, 19(12): 2468-78. [Abstract] [Full-text]
35. A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via a SLAM- and CD46-independent mechanism.
    J Virol, 81(21): 12091-6. [Abstract] [Full-text]
36. Secondary hypertrophic osteoarthropathy associated with solitary fibrous tumor of the lung.
    J Am Acad Dermatol, 57(5): S106-10. [Abstract] [Full-text]
37. Altered expression of splicing factor, heterogeneous nuclear ribonucleoprotein A2/B1, in mouse lung neoplasia.
    Mol Carcinog, 46(11): 887-900. [Abstract] [Full-text]
38. R2 and R2* mapping for sensing cell-bound superparamagnetic nanoparticles: in vitro and murine in vivo testing.
    Radiology, 245(2): 449-57. [Abstract] [Full-text]
39. CUB domain-containing protein 1 is a novel regulator of anoikis resistance in lung adenocarcinoma.
    Mol Cell Biol, 27(21): 7649-60. [Abstract] [Full-text]
40. Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901.
    J Clin Oncol, 25(30): 4736-42. [Abstract] [Full-text]
41. Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer.
    J Clin Oncol, 25(30): 4743-50. [Abstract] [Full-text]
42. Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases.
    J Control Release, 123(2): 123-30. [Abstract] [Full-text]
43. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer.
    J Pathol, 213(3): 294-302. [Abstract] [Full-text]
44. Altered pattern of Cul-1 protein expression and neddylation in human lung tumours: relationships with CAND1 and cyclin E protein levels.
    J Pathol, 213(3): 303-10. [Abstract] [Full-text]
45. Thymic carcinoma in a child with HIV infection.
    Pediatr Blood Cancer, 49(7): 1004-7. [Abstract] [Full-text]
46. Desmoid tumor presenting as a superior sulcus tumor: a unique bone change in the vertebral body.
    Ann Thorac Surg, 84(5): 1752-4. [Abstract] [Full-text]
47. Successful resection of giant solitary pulmonary metastasis from a phyllodes tumor.
    Ann Thorac Surg, 84(5): 1750-2. [Abstract] [Full-text]
48. Is finger palpation at operation indispensable for pulmonary metastasectomy in colorectal cancer?
    Ann Thorac Surg, 84(5): 1680-4. [Abstract] [Full-text]
49. Sublobar resection for patients with peripheral small adenocarcinomas of the lung: surgical outcome is associated with features on computed tomographic imaging.
    Ann Thorac Surg, 84(5): 1675-9. [Abstract] [Full-text]
50. Performance of a computer-aided program for automated matching of metastatic pulmonary nodules detected on follow-up chest CT.
    AJR Am J Roentgenol, 189(5): 1077-81. [Abstract] [Full-text]
51. Activation of nonsteroidal anti-inflammatory drug-activated gene-1 via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase revealed a isochaihulactone-triggered apoptotic pathway in human lung cancer A549 cells.
    J Pharmacol Exp Ther, 323(2): 746-56. [Abstract] [Full-text]
52. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
    Oncogene, 26(49): 7058-66. [Abstract] [Full-text]
53. Oncogenic activation of c-Abl in non-small cell lung cancer cells lacking FUS1 expression: inhibition of c-Abl by the tumor suppressor gene product Fus1.
    Oncogene, 26(49): 6989-96. [Abstract] [Full-text]
54. Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling.
    Oncogene, 26(49): 6968-78. [Abstract] [Full-text]
55. Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis.
    Cancer Sci, 98(12): 2009-18. [Abstract] [Full-text]
56. Inhibition of angiogenesis in the treatment of non-small cell lung cancer.
    Cancer Sci, 98(12): 1825-30. [Abstract] [Full-text]
57. Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer.
    Cancer Sci, 98(12): 1817-24. [Abstract] [Full-text]
58. Fibroblast growth factor receptor 1 oncogene partner as a novel prognostic biomarker and therapeutic target for lung cancer.
    Cancer Sci, 98(12): 1902-13. [Abstract] [Full-text]
59. Primary anaplastic large cell lymphoma of the lung. Report of two cases and literature review.
    Acta Haematol, 118(3): 188-91. [Abstract] [Full-text]
60. Radioactive iodine therapy in poorly differentiated thyroid cancer.
    Nat Clin Pract Oncol, 4(11): 665-8. [Abstract] [Full-text]
61. Rural versus urban colorectal and lung cancer patients: differences in stage at presentation.
    J Am Coll Surg, 205(5): 636-41. [Abstract] [Full-text]
62. Knockdown of PKR expression by RNAi reduces pulmonary metastatic potential of B16-F10 melanoma cells in mice: possible role of NF-kappaB.
    Cancer Lett, 258(1): 118-25. [Abstract] [Full-text]
63. Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1.
    Cancer Lett, 258(1): 80-9. [Abstract] [Full-text]
64. Jaagsiekte sheep retrovirus is not detected in human lung adenocarcinomas expressing antigens related to the Gag polyprotein of betaretroviruses.
    Cancer Lett, 258(1): 22-30. [Abstract] [Full-text]
65. Adaptive radiotherapy planning on decreasing gross tumor volumes as seen on megavoltage computed tomography images.
    Int J Radiat Oncol Biol Phys, 69(4): 1316-22. [Abstract] [Full-text]
66. Verification of in-treatment tumor position using kilovoltage cone-beam computed tomography: a preliminary study.
    Int J Radiat Oncol Biol Phys, 69(4): 970-3. [Abstract] [Full-text]
67. Shrinkage of locally advanced non-small-cell lung cancers in response to induction chemotherapy: implications for radiotherapy treatment planning.
    Int J Radiat Oncol Biol Phys, 69(4): 993-1000. [Abstract] [Full-text]
68. A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data.
    Int J Radiat Oncol Biol Phys, 69(4): 985-92. [Abstract] [Full-text]
69. Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys, 69(4): 1001-7. [Abstract] [Full-text]
70. Video-assisted thoracic surgery lobectomy: report of CALGB 39802--a prospective, multi-institution feasibility study.
    J Clin Oncol, 25(31): 4993-7. [Abstract] [Full-text]
71. Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial.
    J Clin Oncol, 25(31): 4987-92. [Abstract] [Full-text]

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.